Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

857 ARTÍCULOS , VIENDO DEL 166 AL 180

Dexmedetomidine for agitation in dementia: Current data and future direction

Murphy KS, Golden JC, Tampi RR.

J Am Geriatr Soc. 2025 Feb;73(2):552-557. doi: 10.1111/jgs.19196. Epub 2024 Sep 19.

A new GRN variant in logopenic variant primary progressive aphasia: a case report and literature review

Jia SS, Li PL, Gao P, Jiang Y, Zhang CL, Yun WW.

Neurocase. 2025 Feb;31(1):11-16. doi: 10.1080/13554794.2024.2436215. Epub 2024 Dec 4.

Mosaicism in Short Tandem Repeat Disorders: A Clinical Perspective

Doss RM, Lopez-Ignacio S, Dischler A, Hiatt L, Dashnow H, Breuss MW, Dias CM.

Genes (Basel). 2025 Feb 13;16(2):216. doi: 10.3390/genes16020216.

Determining the Role of Sex and APOE4 status on Psychosis in Alzheimer's Disease

Fan J, Churchill N, Fadhel A, Fornazzari LR, De Luca V, Ismail Z, Munoz DG, Schweizer TA, Fischer CE; Alzheimer’s Disease Neuroimaging Initiative.

J Geriatr Psychiatry Neurol. 2025 Jul;38(4):235-240. doi: 10.1177/08919887241313225. Epub 2025 Mar 24.

Preventable adverse events and related outcomes among people with dementia in hospital settings: scoping review

Catalán L, Oliveira D.

Aging Ment Health. 2025 Aug;29(8):1414-1425. doi: 10.1080/13607863.2025.2484355. Epub 2025 Apr 6.

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta I, Videla L, Carmona-Iragui M, Fortea J, Rafii MS.

Alzheimers Dement. 2025 Jun;21(6):e70258. doi: 10.1002/alz.70258.

The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer's Disease

Muñoz de León-López CA, Navarro-Lobato I, Khan ZU.

Biomolecules. 2025 Jun 20;15(7):910. doi: 10.3390/biom15070910.

Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies

Smoller C, Schiller E, Yamashita K, Silverglate BD, Grossberg GT.

Drugs. 2025 Nov;85(11):1391-1411. doi: 10.1007/s40265-025-02227-4. Epub 2025 Sep 6.

Influence of Speech and Language Therapy on Quality of Life in People With Primary Progressive Aphasia: A Scoping Review

Gauch M, Spelter B, Geschke K, Köb AL, Tüscher O, Heinrich I, Corsten S.

Int J Lang Commun Disord. 2025 Sep-Oct;60(5):e70129. doi: 10.1111/1460-6984.70129.

Social cognition in the nonfluent and logopenic variants of primary progressive aphasia: A review of variant-specific profiles

Cordonier N, Piguet O.

Cortex. 2025 Dec;193:171-190. doi: 10.1016/j.cortex.2025.10.007. Epub 2025 Nov 5.

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease

Zhong K, Cummings J.

Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.

Genetic and neurobiological aspects of psychosis in major neurocognitive disorder

Abarca M, Pizarro H, Bustamante ML, Rohde G, Arancibia M.

Medwave. 2025 Jan 8;25(1):e2994. doi: 10.5867/medwave.2025.01.2994.

Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment

Lee HH, Chinnameyyappan A, Feldman OJ, Marotta G, Survilla K, Lanctôt KL.

Curr Top Behav Neurosci. 2025;69:245-273. doi: 10.1007/7854_2024_566.

A US-based practitioner's guide to diagnosis, evaluation, and evidence-based treatment of agitation in Alzheimer's dementia - recommendations of an expert, multispecialty advisory panel

Grossberg GT, Sanford A, Montano CB, Porsteinsson AP, Scanland S, Worz C, McMillian S, Atri A.

Postgrad Med. 2025 Aug;137(6):469-485. doi: 10.1080/00325481.2025.2517535. Epub 2025 Jun 17.

Stem cell-based therapeutic strategies for down syndrome and Alzheimer's disease

Hamadelseed O, Skutella T.

Stem Cell Res Ther. 2025 Aug 5;16(1):420. doi: 10.1186/s13287-025-04556-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias